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Many phylogenetically distant animal viruses, including the new coronavirus severe acute respiratory syn-
drome coronavirus 2, have surface proteins with polybasic sites that are cleaved by host furin and furin-like
proteases. Other than priming certain viral surface proteins for fusion, cleavage generates a carboxy-
terminal RXXR sequence. This C-end Rule (CendR) motif is known to bind to neuropilin (NRP) receptors on
the cell surface. NRPs are ubiquitously expressed, pleiotropic cell surface receptors with important roles in
growth factor signaling, vascular biology, and neurobiology, as well as immune homeostasis and activation.
The CendR–NRP receptor interaction promotes endocytic internalization and tissue spreading of different
cargo, including viral particles. We propose that the interaction between viral surface proteins and NRPs
plays an underappreciated and prevalent role in the transmission and pathogenesis of diverse viruses and
represents a promising broad-spectrum antiviral target.
neuropilin j C-end Rule j virus j internalization
The multitude of viruses with the potential to
unleash global outbreaks, such as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2),
highlights the urgent need to understand how these
pathogens evolve to gain enhanced virulence and
pandemic potential. In particular, identifying the
host factors that control viral infection is essential for
the development of new antiviral strategies and for
the rapid containment of future outbreaks.
To replicate, all viruses must enter a host cell and
transfer their genetic material (1). Viruses gain entry by
hijacking various host proteins (2, 3). Whereas most
virus–receptor interactions involve complex tertiary
protein–protein or carbohydrate–protein interactions,
virus–host interactions can be in some cases mediated by
short (less than seven amino acids) peptide motifs (4).
Such elements include viral surface peptides that are
involved in cell recruitment, such as positively charged
amino acid–containingmotifs that engagewith negatively
charged heparan sulfate polysaccharides on the plasma
membrane (5) as well as arginine– glycine–aspartic acid
(RGD) and related motifs that bind cell surface integrins
(5, 6). Below, we discuss the C-end Rule (CendR)
motif–neuropilin (NRP) receptor interaction as an
emerging viral peptide–cell receptor system, uti-
lized by SARS-CoV-2, that has potentially broad rel-
evance to the cellular entry and pathogenesis of
many viruses (Fig. 1).
CendR Peptides: A Position-Dependent
Cellular Gateway
In screens for tumor-homing peptides, we discov-
ered a novel peptide motif–receptor system that sup-
ports the attachment of various ligands and particles
to the cell surface, triggering their endocytic internal-
ization (7, 8). The motif, R/KXXR/K, is recognized by
the cognate surface receptors NRP-1 and NRP-2.
NRPs are cell surface glycoproteins involved in
vascular patterning and angiogenesis, regulation of
vascular permeability, modulation of the immune
response, and development of the nervous system
(9). The R/KXXR/K motif must be carboxy (C) terminal
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to bind NRPs; therefore, we named the motif CendR. Vascular
endothelial growth factor (VEGF)-A165 and other endogenous
ligands of NRP-1 and NRP-2 harbor a CendR motif, which binds
to a conserved pocket in the extracellular b1 domain of the NRPs
(Fig. 1). VEGF-A165 triggers cellular internalization and vascular
leakage (10), and short peptides with CendR sequences have
similar effects (11), particularly when present in multiple copies
on a molecular scaffold or the surface of a nanoparticle (7).
A striking feature of CendR motifs is their ability to penetrate
tissue—nanoparticles carrying CendR motifs are transported from
the systemic circulation into the extravascular tissue (7, 8). Studies
on the internalization of multivalent CendR nanoparticles showed
that NRP-1 is an endocytic/sorting receptor. NRP-1 mediates an
endocytic pathway similar to macropinocytosis, resulting in the
rapid internalization of the ligand–receptor complex along with
extracellular solutes and macromolecules (12–14). CendR nano-
particle uptake is independent of dynamin, clathrin, caveolin, and
flotillin but depends on actin and on the adaptor protein synectin,
which links NRP-1 to the actin motor protein myosin-6 (Fig. 1)
(12). Following endocytosis, a yet unidentified sorting signal in
NRP-1 mediates intercellular transfer of internalized material,
within membrane-enclosed, Rab5-positive vesicles, at cell-to-cell
contacts (12). This mechanism is important for the tissue penetra-
tion properties of CendR peptides (15).
Whereas early studies on CendR peptides focused on their
application for tumor targeting of drugs, the relevance of the
CendR peptides as a potential determinant of cellular and tissue
tropism of viruses was noted (12).
Furin Convertases and Proteolytic Activation of
Pathogenic Viruses
Viral infection often requires the cleavage of viral surface pro-
teins by host proteases. Proteolytic processing can prime these
viral fusion proteins (F proteins), enabling penetration into the
host cell. The host cell protease furin (also known as paired
basic amino-acid-cleaving enzyme and proprotein convertases
subtilisin/kexin type 3) (16, 17) is an essential and ubiquitously
expressed type I transmembrane serine protease found in the
Golgi apparatus, plasma membrane, endosomal compartments,
and in soluble form in the extracellular space (18). Furin cleaves
after the C-terminal arginine (or lysine) residues of a polybasic
target sequence R/KXXR/K, and furin susceptibility of viruses
correlates with infectivity and interspecies transmission of differ-
ent animal viruses (reviewed in ref. 17).
The best-studied case is the influenza virus hemagglutinin (HA)
spike glycoprotein, which must be cleaved to allow acid-activated
membrane fusion. Low pathogenic avian influenza (LPAI) strains
have HAs with a monobasic cleavage site, susceptible to trypsin-
like proteases, which have restricted expression in the respiratory
and intestinal tracts (19). In contrast, highly pathogenic avian influ-
enza (HPAI) strains have HAs with multiple basic amino acids at
the cleavage site, susceptible to furin and the proprotein conver-
tase 6 (PC6) (20). Whereas HPAI strains show rapid dissemination
with severe systemic infection, destroying vital organs and fre-
quently causing death, the LPAI strains exhibit limited tissue
tropism and cause localized pulmonary and gastrointestinal infec-
tions (21). Nevertheless, the insertion of multiple basic amino
acids at the cleavage site is not always sufficient to convert LPAI
into HPAI (22, 23), and how LPAI viruses evolve into HPAI viruses
is incompletely understood (24, 25). Carboxypeptidase B, incor-
porated in the viral envelope, is capable of cleaving off the
C-terminal arginine of HA1 (26), thereby potentially affecting the
availability of CendR peptides on the viral surface.
Furin susceptibility is also an important pathogenic determi-
nant for the Newcastle disease virus (NDV). The F protein of
avirulent strains of this avian paramyxovirus has a monobasic
cleavage site that is processed in the respiratory system. In con-
trast, the F protein of virulent NDV strains, which spread system-
ically and cause high rates of mortality in infected birds (27), is
cleavable by furin.
Fig. 1. Proteolytically activated engagement of viral spike proteins with NRP receptors. (Left) Upon cleavage of R/KXXR/K sequences by
furin-like PC, viral spikes (green) are “activated” (magenta spikes) and acquire the ability to bind to NRP receptors. The C-terminal arginine
(magenta) of the cleaved viral peptide can interact with the binding pocket in the b1 domain of NRP (blue). On the cytoplasmic side, the post-
synaptic density protein (PSD95), Drosophila disc large tumor suppressor (Dlg1), and zonula occludens-1 protein (zo-1) (PDZ)–binding domain
(PDZ-bd) of NRP can bind to PDZ-containing proteins and with other receptors, activate different cellular functions, including endocytosis,
signaling, intracellular trafficking, and cell-to-cell transport (transcytosis). In Right, the numbers of amino acids (aa) comprising the flexible
parts of NRP-1 are indicated on the right. Protein Data Bank ID codes for NRP-1 are 5l73 and 4gz9. Flexible linkers of NRP-1 are modeled
using the Coot software. MAM, meprin, A5, receptor protein tyrosine phosphatase mu; PM, plasma membrane.
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The coronavirus spike envelope glycoprotein (S protein) is
the main determinant of viral interaction with the host cell sur-
face. Its proteolytic activation at mono- or polybasic sequences
is a critical checkpoint that regulates coronavirus cell entry, tis-
sue and cell tropism, host range, and pathogenicity (28). For
efficient infection, each subunit of the homotrimeric S protein is
cleaved at least once, at the S2’ site. In some coronaviruses
(e.g., SARS-CoV-2 and Middle East respiratory syndrome
[MERS]), an additional cleavage occurs at the S1/S2 site. Cleav-
age at S2’ is required to expose the fusogenic portion of the
spike (sometimes referred to as the “fusion peptide”), which
inserts into the host cell membrane to promote fusion. The S1/
S2 site enhances infection in primary cells and in vivo. Interest-
ingly, among lineage B β-coronaviruses, only the SARS-CoV-2 S
protein contains a polybasic furin cleavage site RRAR at the
junction of S1 and S2 domains, due to insertion of 12 nucleoti-
des in the viral genome (29).
NRPs as Viral Entry Factors
According to the common paradigm, proteolytic cleavage trans-
forms viral surface proteins into a metastable conformation
required for productive infection, a molecular “mousetrap”
ready to trigger membrane fusion.
However, proteolytic processing of viral proteins by furin has
a consequence that has received little attention; it converts pol-
ybasic sequence motifs within proteins into CendR peptides
that can potentially interact with widely expressed NRP recep-
tors. Indeed, some endogenous substrates of furin, such as class
3 semaphorins, bind to NRPs as their cell surface coreceptors
(30–32). Seven viruses to date have been shown to use NRPs as
cellular (co-)receptors: the coronavirus SARS-CoV-2 (33, 34), ret-
roviruses human T cell lymphotropic virus-1 (HTLV-1) and HTLV-
2 (35, 36), the herpesviruses Epstein-Barr virus (EBV) (37, 38),
mouse cytomegalovirus (mCMV) (39), human cytomegalovirus
(hCMV) (40), and the arenavirus Lujo virus (LUJV) (41, 42) (Table
1). The spike glycoproteins of all these viruses contain polybasic
sites that are cleaved or can potentially be cleaved by a PC.
Furin cleavage of viral envelope glycoproteins occurs in phylo-
genetically distant virus families, including Herpes-, Corona-,
Flavi-, Toga-, Borna-, Bunya-, Phyllo-, Orthomyxo-, Paramyxo-,
Pneumo-, Retro-, and the nonenveloped Papillomaviridae (17)
(SI Appendix, Table S1). For most of these viruses, furin-
mediated cleavages are essential for virus entry and infectivity,
and the cleavage products remain associated with the viral
particle. We propose that the CendR–NRP interaction could be
an underappreciated but critical common pathway used for
enhanced infection by PC-activated viruses. In addition to
CendR sequences, other regions of the viral spike proteins can
interact with NRPs (e.g., the pentamer of hCMV).
In the case of SARS-CoV-2, X-ray crystallography of a pep-
tide corresponding to the furin-cleaved C end of S1 (sequence:
SPRRAR) in complex with NRP-1 b1 domain revealed a consen-
sus CendR interaction with the C-terminal arginine of the spike
peptide entering the binding pocket of the b1 domain of NRP-1
(34), similar to prototypical NRP-1 ligands (Fig. 1). The binding
to NRP-1 appears to be stabilized by additional interaction(s) in
other regions of the spike (34).
HTLV-1 and EBV also appear to bind NRP via a canonical
CendR interaction, as suggested by competition using full-
length VEGFA-165, its C-terminal CendR peptide KPRR, or the
soluble b1b2 ectodomain of NRP-1 (35–38). The HTLV-1 interac-
tion with NRP-1 involves additional bridging using heparan sul-
fate proteoglycans (36), similar to the interactions between
NRP-1 and CendR nanoparticles (13), as well as VEGF165 (43).
The NRP-1–mediated endocytic mechanism of EBV is dynamin,
clathrin, and caveolin independent and based on fluid uptake
studies and on small molecule inhibitors sensitivity profiling,
resembles macropinocytosis (37). Endocytosed virus–NRP-1
complexes accumulate in intracellular vesicles positive for sort-
ing nexin 5 (SNX5), a protein enriched in macropinosomes (37).
Interestingly, VEGFR2 bound to VEGFA165, the isoform that
binds to NRP-1, is also internalized by macropinocytosis and
accumulates in SNX5 vesicles (44).
hCMV and LUJV use NRP-2 as an entry factor (40–42) in
nasopharyngeal epithelial cells.
Physiologically, the two NRP homologs, NRP-1 and NRP-2,
bind to both overlapping and distinct members of the VEGF and
Sema3 families. For example, whereas Nrp-1 specifically binds the
VEGF-A164/5 isoform and Sema3A, NRP-2 binds VEGF-C and
Sema3F (9). CendR-binding b1 domains of NRP-1 and NRP-2
show conservation of residues in the binding pocket critical for
C-terminal arginine binding and variability within amino acid resi-
dues surrounding the interloop cleft (45); this variability and
involvement of secondary binding sites are thought to contribute
to differences in ligand binding profiles between NRP-1 and
NRP-2 (9). NRP-1 and NRP-2 also show isoform-dependent differ-
ences in endocytic routes and the intracellular destination of
the ligand–partner receptor complexes: recycling endosomes for











and cells in vivo Viral family Genome Host Disease Refs.
SARS-CoV-2 NRP-1 ACE2 S Yes HEK,* Caco2, Calu-3 Coronaviridae +RNA Human SARS 33, 34
HTLV1 NRP-1 Glut-1, HSPG Env Yes HeLa, DCs, T cells Retroviridae +RNA/DNA Human T cell leukemia 35, 36
EBV NRP-1 Ephr-A2 gB Yes Nasopharyngeal
epithelial cells




mCMV NRP-1 n.d. n.d. n.d. Endothelial cells Herpesviridae DNA Mouse Mostly asymptomatic 39
hCMV NRP-2 CD46 Pentamer n.d. Nasopharyngeal
epithelial and
endothelial cells
Herpesviridae DNA Human Birth complications,
mononucleosis
40
LUJV NRP-2 CD63/LAMP1 GP n.d. Hap1, HEK,
endothelial
Arenaviridae RNA Human Fatal hemorrhagic fever 41, 42
SARS, severe acute respiratory syndrome; DCs, dendritic cells; n.d., not determined.
*HEK cells are susceptible to SARS-CoV-2 only after exogenous expression of ACE2 and TMPRSS2.
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NRP-1 and late endosomes and lysosomes for NRP-2. NRP-1
guides the VEGFR2/VEGFA complex to the Rab-11 recycling com-
partment. Depletion of NRP-1 results in redirecting the complex to
degradative lysosomes, which results in the termination of signal-
ing (46). On the other hand, NRP-2 has an opposite effect; in the
presence of NRP-2, epidermal growth factor receptor (EGFR)–
epidermal growth factor (EGF) complexes are targeted for degra-
dation (47). During viral entry, the choice of the NRP isoform may
have a profound effect on viral infection, and the preference of
one NRP isoform over the other may be dictated by the elements
of viral life cycle such as pH or protease required for efficient
membrane fusion. In the case of EBV, for instance, NRP-1 enhan-
ces entry and infection, whereas NRP-2 is inhibitory (34–37).
Importantly, genome delivery of LUJV takes place in late endo-
somes and lysosomes, supporting the potential contribution of
NRP-2 in virus trafficking to these compartments (41, 48).
NRPs are (co-)receptors, and physiological ligands of NRP
typically bind a second receptor (e.g., VEGF also binds to
VEGFR, and SEMA3A also binds to plexin receptors) (9). Simi-
larly, NRP-interacting viruses seem to use additional receptors
for cell binding (e.g., ACE2 for SARS-CoV-2 or Ephrin receptor
A2 for EBV) (Table 1). Although the cell surface, particularly the
apical membrane of epithelial cells, is rich in proteases, proteo-
lytic CendR activation and NRP engagement may require the
high-affinity binding of the viral particle to the primary receptor
on the plasma membrane.
NRPs show remarkable structural flexibility and can accom-
modate ligands and partner receptors of different geometries
(Fig. 2), in line with a potential role as multivirus entry/penetra-
tion (co-)factors. For a trimeric viral spike, up to three NRP mole-
cules could bind at the same time. A structural comparison of
viral spikes that harbor polybasic cleavage sites cleaved, or
potentially cleaved, by furin-like convertases shows the pres-
ence of water-exposed CendR sequences either on the side of
the trimer (e.g., in the case of SARS-CoV-2 and MERS S [Coro-
naviridae], influenza HA [Orthomyxoviridae], respiratory syncy-
tial virus F [RSV; Pneumoviridae], HIV-1 Env [Retroviridae], and
Ebola Zaire virus glycoprotein [GP] [Filoviridae]) or at the fore-
front of the spike (e.g., in hCMV glycoprotein B [gB] [Herpesviri-
dae] and LUJV GP [Arenaviridae]) (Fig. 2). The flexible parts of
the NRP could stretch to reach a CendR peptide exposed on
the spike (Fig. 2, center). Following NRP engagement, the force
generated by the actin–myosin network coupled to the cyto-
plasmic PDZ-binding domain of NRP (Fig. 2) could potentially
act as a destabilizing factor for the viral spike to facilitate mem-
brane fusion. In line with the role of NRP-1 in SARS-CoV-2
cell–cell fusion (i.e., syncytia formation) (34), the interaction
between NRP-1 and S may facilitate the exposure of the second
cleavage site (S2’ in SARS-CoV-2 S) (49), bringing this region of
the spike to proximity with smaller membrane proteases such as
TMPRSS2 (Fig. 2, center). The role of NRP-1 in SARS-CoV-2
infection has not yet been investigated in the epithelial cells of
the upper and lower respiratory tracts, where fusion is thought
to occur directly at the cell surface rather than in endosomes.
The potential facilitation of viral fusion could play an important
role in the virus penetration of ciliated polarized epithelial cells,
the primary target of SARS-CoV-2. Of note, systemic nanopar-
ticles coated with the CendR peptides show robust microvascu-
lar pulmonary accumulation and penetration (7), raising an
intriguing possibility of circulation-mediated secondary lung
infection. Additional structural and functional studies are
required to solve the mechanisms and consequences of NRP
engagement with viral spikes.
CendR in Viral Infection: The Path Forward
Based on the existing data, we propose that many different
viruses ultimately expose CendR peptides to bind NRP, facilitat-
ing infection and pathogenesis. As a variation to this rule, some
viral spikes, such as the pentamer of hCMV, can bind NRPs in
the absence of consensus CendR motif. Binding to NRP (co-
)receptors could contribute to viral infectivity and pathogenesis
in several ways.
1) Promoting cellular uptake. Interaction of CendR peptides
with NRP triggers robust cell internalization, particularly when
Fig. 2. Hypothetical interaction model of SARS-CoV-2 spike with
entry factors NRP-1 and ACE2 and position of CendR sequences on
the spikes of different viruses. The approximate position of the
CendR sequence on the trimeric spikes of the respective viruses is
indicated by the magenta dots. The three subunits of each trimeric
spike are colored in purple, green, and orange. The position of the
viral membrane is indicated by the gray line. In the center, the spike
of SARS-CoV-2 is binding one ACE2 monomer (gray). The position
of the furin-cleaved CendR sequence is indicated in magenta. The
b1 domain on NRP is indicated in blue. The virus-activating serine
protease TMPRSS2 is shown, and the position of the respective S2’
cleavage site on the spike is indicated by a cyan spot. On the cyto-
plasmic side, the PDZ-binding domain of NRP-1 binds through syn-
ectin to the myosin-6/actin cytoskeleton. All structures were
obtained from the Protein Data Bank (PDB) database: SARS-CoV-2
S/ACE2 (7knb, 6m1d), MERS S (7knb), RSV F (6q0s), HIV-1 Env
(6mtj), Ebola GP (5jq7), HCMV gB (7kdp), and Influenza HA (2ibx).
The long flexible parts between the plasma membrane and NRP-1
meprin, A5, receptor protein tyrosine phosphatase mu (MAM) (PBD
ID code 5l73) domain, the MAM and the b1b2a1a2 (PDB ID code
4gz9) domains, as well as the part between the plasma membrane
and catalytic domain of TMPRSS2 (PDB ID code 7meq) were mod-
eled using Coot software based on the maximal length of the 40 to
41 (NRP-1) and 42 (TMPRSS2) amino acids in the primary sequence
of the respective proteins.
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multiple copies of the CendR peptides are displayed on the
surface of virus-sized nanoparticles (7, 12).
2) Enabling tissue spreading. CendR peptides support trans-tis-
sue transport across biological barriers commonly invaded by
viruses (e.g., epithelial, vascular, olfactory, and blood–brain
barriers) (7, 33, 50).
3) Competing with endogenous ligands. For example, the
SARS-CoV-2 S trimer competes with VEGF binding to NRP-1
in pain sensory neurons, causing an analgesic effect (51).
Analogous competition with other NRP-1 ligands could mod-
ulate signaling pathways to affect virus entry, protein synthe-
sis, and spreading.
4) Suppressing the antiviral immune response. NRPs are impor-
tant regulators of innate and adaptive immunity with key roles
in inflammation, immune homeostasis, and surveillance (52).
NRP-1 is expressed in macrophages (53, 54), is part of immu-
nological synapses (55), and regulates the activity of different
T cells (56–58). By binding to NRP, viral spikes could interfere
with these immune functions.
5) Modulating signaling cascades. NRPs are well-known multili-
gand hub receptors of important growth factors (e.g., VEGF,
PlGF, TGF-β, PDGF-B, FGF, EGF, and HGF) (59). Whereas the
cytoplasmic side of NRP has not been associated with kinase
activity, virus-bound NRP could, by partnering with and coac-
tivating signaling receptors, modulate signaling cascades
involved in remodeling of cytoskeleton, macropinocytosis,
cell survival, and protein synthesis.
Research into the role of CendR–NRP in viral infection is
needed to address outstanding questions. For instance, do all
viruses that contain polybasic processing sites use NRP for
enhanced infectivity? Interestingly, for phage displayed pepti-
des, a single C-terminal arginine suffices for NRP binding (7),
and split complement proteins with a monobasic C-terminal
sequence bind NRP (60).
From the cell perspective, how does the CendR pathway
affect the trafficking of viral particles and infection in vivo? How
does viral hijacking of the CendR pathway affect physiological
functions of NRP, and what are the pathological consequences
of viral modulation of the CendR pathway? Moreover, studies
on the uptake of multivalent CendR nanoparticles indicated that
nutrient starvation and stress conditions enhance NRP-
1–dependent particle uptake (12). So, would these conditions
enhance infection by CendR-displaying viruses? Finally, is the
CendR pathway relevant to zoonotic spread of viruses? Does
the conservation of the CendR binding pocket in NRP across
vertebrates render furin-activated viruses particularly prone to
the transmission from a reservoir population to a new host
species?
The answers to these questions, while unlikely to be simple
and straightforward, may establish a novel paradigm: NRPs as
(co-)receptors shared by a multitude of proteolytically activated
pathogenic viruses. This finding could inform broad-spectrum
antivirals that act by regulating NRP or CendR convertases in
cells or by blocking the conserved CendR peptides on viruses.
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